Article Dans Une Revue (Article De Synthèse) Vietnamese Journal of Legal Sciences Année : 2021

Big Pharma and Investment Arbitration

Résumé

Investment Arbitration in the pharmaceutical sector raises some specificities. Regarding jurisdiction of arbitral tribunals, it is questionable whether the registration of a patent abroad or a patent license granted to a foreign partner constitutes an investment. Similarly, as health products are not ordinary goods, arguments according to which marketing authorizations or monopolies granted constitute an investment are real issues. On the merits, the invalidation of a patent, the refusal or withdrawal of a marketing authorization or the decision of a state authority to end a monopoly can be analyzed as a violation of some of the commitments made by States in the treaties they conclude. The aim of this study is to address these questions thanks to the awards already rendered, making it a useful tool for countries -like Vietnam- that wish to develop their pharmaceutical sector by attracting foreign investors.

Fichier principal
Vignette du fichier
Big-Pharma-and-Investment-Arbitration.pdf (133.94 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04346666 , version 1 (17-09-2025)

Licence

Identifiants

Citer

Sébastien Manciaux. Big Pharma and Investment Arbitration. Vietnamese Journal of Legal Sciences, 2021, 4 (1), pp.88-114. ⟨10.2478/vjls-2021-0010⟩. ⟨hal-04346666⟩
40 Consultations
93 Téléchargements

Altmetric

Partager

  • More